Results 21 to 30 of about 9,355,841 (357)

Risk Aversion is Associated with Decision Making among Community-Based Older Persons

open access: yesFrontiers in Psychology, 2012
Background: Risk aversion is associated with many important decisions among younger and middle aged persons, but the association of risk aversion and decision making has not been well studied among older persons who face some of the most significant ...
Patricia eBoyle   +3 more
doaj   +1 more source

The amyloid hypothesis of Alzheimer's disease at 25 years

open access: yesEMBO Molecular Medicine, 2016
Despite continuing debate about the amyloid β‐protein (or Aβ hypothesis, new lines of evidence from laboratories and clinics worldwide support the concept that an imbalance between production and clearance of Aβ42 and related Aβ peptides is a very early,
D. Selkoe, J. Hardy
semanticscholar   +1 more source

Metals in Alzheimer’s Disease

open access: yesBiomedicines, 2023
The role of metals in the pathogenesis of Alzheimer’s disease (AD) is still debated. Although previous research has linked changes in essential metal homeostasis and exposure to environmental heavy metals to the pathogenesis of AD, more research is needed to determine the relationship between metals and AD.
Mirjana Babić Leko   +5 more
openaire   +4 more sources

NETosis in Alzheimer’s Disease [PDF]

open access: yesFrontiers in Immunology, 2017
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the progressive deterioration of cognitive functions. Its neuropathological features include amyloid-β (Aβ) accumulation, the formation of neurofibrillary tangles, and the loss of neurons and synapses.
Pietronigro, Enrica Caterina   +3 more
openaire   +4 more sources

Microbes and Alzheimer’s Disease

open access: yesJournal of Alzheimer's Disease, 2016
descripción no proporcionada por ...
Judith A. Whittum-Hudson   +33 more
openaire   +11 more sources

On the reconceptualization of Alzheimer’s disease [PDF]

open access: yesBioethics, 2018
AbstractIn the hope of future treatments to prevent or slow down the disease, there is a strong movement towards an ever‐earlier detection of Alzheimer’s disease (AD). In conjunction with scientific developments, this has prompted a reconceptualization of AD, as a slowly progressive pathological process with a long asymptomatic phase. New concepts such
Maartje H. N. Schermer, Edo Richard
openaire   +6 more sources

Deep learning improves utility of tau PET in the study of Alzheimer's disease

open access: yesAlzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021
Introduction Positron emission tomography (PET) imaging targeting neurofibrillary tau tangles is increasingly used in the study of Alzheimer's disease (AD), but its utility may be limited by conventional quantitative or qualitative evaluation techniques ...
James Zou   +12 more
doaj   +1 more source

Differentiating among stages of cognitive impairment in aging: Version 3 of the Uniform Data Set (UDS) neuropsychological test battery and MoCA index scores

open access: yesAlzheimer’s & Dementia: Translational Research & Clinical Interventions, 2020
Introduction Federally funded Alzheimer's Disease Centers in the United States have been using a standardized neuropsychological test battery as part of the National Alzheimer's Coordinating Center Uniform Data Set (UDS) since 2005. Version 3 (V3) of the
Hiroko H. Dodge   +22 more
doaj   +1 more source

New insights into the genetic etiology of Alzheimer’s disease and related dementias

open access: yesNature Genetics, 2022
Characterization of the genetic landscape of Alzheimer’s disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes.
C. Bellenguez   +402 more
semanticscholar   +1 more source

Psychosis in Alzheimer’s Disease [PDF]

open access: yesCurrent Neurology and Neuroscience Reports, 2020
AbstractPurpose of ReviewTo review the incidence, treatment and genetics of psychosis in people with mild cognitive impairment (MCI) and Alzheimer’s disease (AD).Recent FindingsPsychosis in Alzheimer’s disease (AD) has an incidence of ~ 10% per year. There is limited evidence regarding psychological interventions. Pharmacological management has focused
Robert A. Sweet   +8 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy